{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:29:05Z","timestamp":1767677345569,"version":"3.48.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>LAMA2<\/jats:italic>\n                      -related congenital muscular dystrophy (\n                      <jats:italic>LAMA2<\/jats:italic>\n                      -MD) is a genetically heterogeneous disorder defined by progressive muscle weakness, brain structural abnormalities, epilepsy, and multisystem involvement. The primary goal of this study was to characterize the clinical features, temporal progression, and genotype-phenotype correlations of\n                      <jats:italic>LAMA2<\/jats:italic>\n                      -MD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Medical records of patients with genetically confirmed\n                      <jats:italic>LAMA2<\/jats:italic>\n                      -MD were extracted from a clinical data repository and analyzed retrospectively. Clinical manifestations, laboratory findings, and neuroimaging features were systematically reviewed and compared across different age groups. Variant data were retrieved from public databases to perform comprehensive genetic analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of five patients (two males and three females) were enrolled, delayed motor milestones and varying degrees of ankle contractures and persistent motor impairment in all patients were the initial presenting symptom at diagnosis in all cases, and two patients also exhibited cognitive delays. Laboratory analysis of muscle enzymes showed varying degrees of abnormalities, with creatine kinase (CK) levels displaying the most significant elevation. Cranial magnetic resonance imaging (MRI) revealed symmetrical white matter abnormalities in four patients. Seizures were documented in three school-aged patients. All patients carried compound heterozygous variants in the\n                      <jats:italic>LAMA2<\/jats:italic>\n                      gene. A literature review indicated that the most common variant types were stop-gain and missense variants: stop-gain variants were predominantly associated with complete merosin deficiency (MDC1A), whereas missense variants typically correlated with late-onset limb-girdle muscular dystrophy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>LAMA2<\/jats:italic>\n                      -MD exhibits a broad phenotypic spectrum and a progressive disease course. Early manifestations include muscle weakness, delayed achievement of developmental milestones, joint contractures, seizures and characteristic intracranial abnormalities.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1728652","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:20:15Z","timestamp":1767676815000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["LAMA2 variants associated with muscular dystrophy, brain structural abnormalities, and epilepsy: a genotype-phenotype study"],"prefix":"10.3389","volume":"16","author":[{"given":"Jian","family":"Zha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoshi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"ref1","first-page":"351","article-title":"Congenital muscular dystrophy with merosin deficiency","volume":"317","author":"Tome","year":"1994","journal-title":"C R Acad Sci III"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02185752","article-title":"Genetic epidemiology of congenital muscular dystrophy in a sample from North-East Italy","volume":"97","author":"Mostacciuolo","year":"1996","journal-title":"Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(SICI)1097-0029(20000201\/15)48:3\/4<>3.0.CO;2-Q","article-title":"Merosin and congenital muscular dystrophy","volume":"48","author":"Miyagoe-Suzuki","year":"2000","journal-title":"Microsc Res Tech"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/cge.13560","article-title":"Congenital muscular dystrophies in China","volume":"96","author":"Ge","year":"2019","journal-title":"Clin Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mus.22132","article-title":"Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations","volume":"44","author":"Gavassini","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: toward a more comprehensive picture of the laminin-alpha2 variome and its related phenotypes","volume":"39","author":"Oliveira","year":"2018","journal-title":"Hum Mutat"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"825390","DOI":"10.3389\/fnmol.2022.825390","article-title":"Recessive LAMA5 variants associated with partial epilepsy and spasms in infancy","volume":"15","author":"Luo","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.ejhg.5200743","article-title":"Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin)","volume":"10","author":"Allamand","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1083\/jcb.124.3.381","article-title":"Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and a chain in human fetal tissues","volume":"124","author":"Vuolteenaho","year":"1994","journal-title":"J Cell Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/dvdy.24473","article-title":"Adhesion G-protein coupled receptors and extracellular matrix proteins: roles in myelination and glial cell development","volume":"246","author":"Mehta","year":"2017","journal-title":"Dev Dyn"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.seizure.2021.07.020","article-title":"Epilepsy in LAMA2-related muscular dystrophy: a systematic review of the literature","volume":"91","author":"Salvati","year":"2021","journal-title":"Seizure"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cge.12366","article-title":"Genotype\/phenotype analysis in Chinese laminin-alpha2 deficient congenital muscular dystrophy patients","volume":"87","author":"Xiong","year":"2015","journal-title":"Clin Genet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.7499\/j.issn.1008-8830.2001102","article-title":"Clinical features and LAMA2 mutations of patients with congenital muscular dystrophy type 1A: a case report and literature review","volume":"22","author":"Guo","year":"2020","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JND-221638","article-title":"Brain MRI abnormalities, epilepsy and intellectual disability in LAMA2 related dystrophy - a genotype\/phenotype correlation","volume":"10","author":"Camelo","year":"2023","journal-title":"J Neuromuscul Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.nmd.2010.02.001","article-title":"Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations","volume":"20","author":"Geranmayeh","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.seizure.2023.08.008","article-title":"Recessive APC2 missense variants associated with epilepsies without neurodevelopmental disorders","volume":"111","author":"Jin","year":"2023","journal-title":"Seizure"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2024.10.007","article-title":"CCDC22 variants caused X-linked focal epilepsy and focal cortical dysplasia","volume":"123","author":"He","year":"2024","journal-title":"Seizure"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1290919","DOI":"10.3389\/fnmol.2023.1290919","article-title":"DLG3 variants caused X-linked epilepsy with\/without neurodevelopmental disorders and the genotype-phenotype correlation","volume":"16","author":"He","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1111\/epi.18358","article-title":"De novo TANC2 variants caused developmental and epileptic encephalopathy and epilepsy","volume":"66","author":"Luo","year":"2025","journal-title":"Epilepsia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18695","article-title":"De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum","author":"Liang","year":"2025","journal-title":"Epilepsia"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"107097","DOI":"10.1016\/j.yebeh.2020.107097","article-title":"Developmental and epileptic encephalopathy due to SZT2 genomic variants: emerging features of a syndromic condition","volume":"108","author":"Trivisano","year":"2020","journal-title":"Epilepsy Behav"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3760\/cma.j.issn.0578-1310.2017.02.008","article-title":"Peripheral nerve injury in LAMA2-related congenital muscular dystrophy patients","volume":"55","author":"Liang","year":"2017","journal-title":"Zhonghua Er Ke Za Zhi"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1728652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:20:18Z","timestamp":1767676818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1728652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":23,"alternative-id":["10.3389\/fneur.2025.1728652"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1728652","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"1728652"}}